(Q46564805)

23 December 2017

title

Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension (English)

1 reference

23 December 2017

5

Roland Veelken

1 reference

23 December 2017

Roland E. Schmieder

4

object named as

Roland E Schmieder

1 reference

23 December 2017

author name string

Bernd Klanke

1

1 reference

23 December 2017

Nada Cordasic

2

1 reference

23 December 2017

Andrea Hartner

3

1 reference

23 December 2017

Karl F Hilgers

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

30 May 2008

1 reference

23 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

11

1 reference

23 December 2017

page(s)

3456-3463

1 reference

23 December 2017

Mechanisms of hypertension: the expanding role of aldosterone

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Rapid nongenomic effects of aldosterone on human forearm vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Aldosterone target organ protection by eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Participation of the mineralocorticoid receptor in cardiac and vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Pathophysiology of hypertensive renal damage: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Effect of celecoxib on experimental liver fibrosis in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Nongenomic vascular action of aldosterone in the glomerular microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Macrophages and progressive tubulointerstitial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Aldosterone increases osteopontin gene expression in rat endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin-angiotensin system in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Oxidative stress in aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN301

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN301

1 reference

23 December 2017

1 reference

23 December 2017